Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
Authors
Keywords
Triple negative breast cancer, Non-small cell lung cancer, Paclitaxel, gene delivery, Doxorubicin, Cancer-stem cell
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 337, Issue -, Pages 27-58
Publisher
Elsevier BV
Online
2021-07-14
DOI
10.1016/j.jconrel.2021.07.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
- (2021) Mukaddes Izci et al. CHEMICAL REVIEWS
- Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer
- (2020) Ruda Lee et al. BIOCONJUGATE CHEMISTRY
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FDA Approval Summary: Atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1
- (2020) Preeti Narayan et al. CLINICAL CANCER RESEARCH
- Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles
- (2020) Yiliang Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
- (2020) K.G.K. Deepak et al. PHARMACOLOGICAL RESEARCH
- Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms
- (2020) Tsai-Tsen Liao et al. Cells
- EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer
- (2020) Ankita Sanjay Burande et al. AAPS PHARMSCITECH
- α3β1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment
- (2020) Yan Zou et al. ACS Applied Materials & Interfaces
- Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer
- (2020) Ziying Li et al. Acta Biomaterialia
- Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
- (2020) Kendall B. Wallace et al. CIRCULATION RESEARCH
- Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors
- (2020) Johanna M. Schafer et al. Science Translational Medicine
- Cantharidin‐loaded functional mesoporous titanium peroxide nanoparticles for non‐small cell lung cancer targeted chemotherapy combined with high effective photodynamic therapy
- (2020) Kun Zheng et al. Thoracic Cancer
- Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
- (2020) Mauricio A. Medina et al. International Journal of Environmental Research and Public Health
- Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
- (2020) Jin Sun Lee et al. Cancers
- Metabolic Reprogramming in Triple-Negative Breast Cancer
- (2020) Xiangyu Sun et al. Frontiers in Oncology
- Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer
- (2020) Sibusiso Alven et al. Pharmaceutics
- Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
- (2020) Nataša Avramović et al. Pharmaceutics
- Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
- (2020) Mohamed Haider et al. Pharmaceutics
- Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles
- (2020) Asiye Akbarian et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
- (2020) Yun Liu et al. JOURNAL OF CONTROLLED RELEASE
- Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer
- (2020) Hebao Yuan et al. MOLECULAR PHARMACEUTICS
- Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
- (2020) Tuo Wei et al. Nature Communications
- Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy
- (2020) Rasha S. Elbatanony et al. Drug Delivery and Translational Research
- Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer
- (2020) Zhen Zhao et al. Science Advances
- Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
- (2020) Coral García-Fernández et al. Cancers
- Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
- (2020) Bin Tu et al. Frontiers in Cell and Developmental Biology
- Low molecular weight polyethyleneimine conjugated guar gum for targeted gene delivery to triple negative breast cancer
- (2020) Piyali Jana et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
- (2020) Vikas Jain et al. JOURNAL OF CONTROLLED RELEASE
- CRISPR-Cas9 Genome-Wide Knockout Screen Identifies Mechanism of Selective Activity of Dehydrofalcarinol in Mesenchymal Stem-like Triple-Negative Breast Cancer Cells
- (2020) Corena V. Grant et al. JOURNAL OF NATURAL PRODUCTS
- The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer
- (2020) J.M. Varlotto et al. LUNG CANCER
- Optimization and efficacy study of synergistic vincristine coloaded liposomal doxorubicin against breast and lung cancer
- (2020) Saikat Ghosh et al. Nanomedicine
- Synergistic co-loading of vincristine improved chemotherapeutic potential of Pegylated liposomal doxorubicin against triple negative breast cancer and non-small cell lung cancer
- (2020) Saikat Ghosh et al. Nanomedicine-Nanotechnology Biology and Medicine
- Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers
- (2020) Shahriar Sharifi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials
- (2020) Daniele Marinelli et al. Cancers
- Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements
- (2020) Dima Hattab et al. Pharmaceutics
- Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies
- (2019) Saikat Ghosh et al. JOURNAL OF CONTROLLED RELEASE
- Cetuximab and Doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparticles as novel targeted nanocarriers for non-small cell lung cancer
- (2019) Qinlu Zhang et al. JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
- Targeting Cancer Cell Dormancy
- (2019) Ariadna Recasens et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
- (2019) Catarina Silva et al. Pharmaceutics
- Clinical Trials of Thermosensitive Nanomaterials: An Overview
- (2019) Stefania Nardecchia et al. Nanomaterials
- Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
- (2019) Jingsi Dong et al. Frontiers in Pharmacology
- A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
- (2019) Guillermo Prado-Vázquez et al. Scientific Reports
- Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology
- (2019) Panagiotis Ntellas et al. Oncotarget
- Safety and efficacy of atezolizumab in the treatment of cancers: a systematic review and pooled-analysis
- (2019) Yan Tie et al. Drug Design Development and Therapy
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Recent therapeutic trends and promising targets in triple negative breast cancer
- (2019) Soo-Yeon Hwang et al. PHARMACOLOGY & THERAPEUTICS
- Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer
- (2019) Chengxiang Zhang et al. Nano Research
- Targeted Lipid Nanoemulsions Encapsulating Epigenetic Drugs Exhibit Selective Cytotoxicity on CDH1–/FOXM1+ Triple Negative Breast Cancer Cells
- (2019) Bumjun Kim et al. MOLECULAR PHARMACEUTICS
- Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
- (2019) Matt Shirley DRUGS
- Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
- (2019) J. Gao et al. Clinical & Translational Oncology
- Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
- (2019) Francesca Nazio et al. CELL DEATH AND DIFFERENTIATION
- Recent advances in triple negative breast cancer: the immunotherapy era
- (2019) Antonio Marra et al. BMC Medicine
- ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
- (2019) Gina Rosas et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Emerging therapies for non-small cell lung cancer
- (2019) Chao Zhang et al. Journal of Hematology & Oncology
- An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
- (2019) Mohamed F. Attia et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells
- (2019) Meng Yang et al. OncoTargets and Therapy
- Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
- (2019) Jing-Jing Liu et al. Artificial Cells Nanomedicine and Biotechnology
- Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
- (2019) Beatriz García-Pinel et al. Nanomaterials
- Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles
- (2019) Aditi Mehta et al. PHARMACEUTICAL RESEARCH
- Insights into new mechanisms and models of cancer stem cell multidrug resistance
- (2019) Y. Garcia-Mayea et al. SEMINARS IN CANCER BIOLOGY
- Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates
- (2019) Koita Sacko et al. Nanomaterials
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
- (2019) Santoni-Rugiu et al. Cancers
- Recent Progress in the Development of Poly(lactic-co-glycolic acid)-Based Nanostructures for Cancer Imaging and Therapy
- (2019) Ki-Taek Kim et al. Pharmaceutics
- Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine
- (2019) Amanda K. Pearce et al. BIOCONJUGATE CHEMISTRY
- Hyaluronic acid-coated pH sensitive poly (β-amino Ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment
- (2019) Yingqi Xu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models
- (2019) Massimo Moro et al. JOURNAL OF CONTROLLED RELEASE
- EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer
- (2019) Elif Asik et al. Nanomedicine
- Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
- (2019) Daphné Morel et al. Nature Reviews Clinical Oncology
- Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel
- (2019) Peng Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Oncogenic BRAF: Past, Present, and Future
- (2019) Zaman et al. Cancers
- Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
- (2019) Kha-Liang Lee et al. Cancers
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- RPV‐modified Epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply
- (2019) Liang Kong et al. CANCER SCIENCE
- A novel pH-sensitive polymeric prodrug was prepared by SPAAC click chemistry for intracellular delivery of doxorubicin and evaluation of its anti-cancer activity in vitro
- (2019) Jiahui He et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer
- (2019) Ramanathan Karuppasamy et al. SEMINARS IN CANCER BIOLOGY
- High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple-Negative Breast Cancer
- (2019) Lin et al. Pharmaceutics
- Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor—Afatinib: In vitro and in vivo evaluation
- (2019) Jinli Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer
- (2019) Moataz Reda et al. CANCER LETTERS
- Dual-targeting liposomes with active recognition of GLUT5 and αvβ3 for triple-negative breast cancer
- (2019) Yanchi Pu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Surface engineered liposomal delivery of therapeutics across the blood brain barrier: recent advances, challenges and opportunities
- (2019) Saikat Ghosh et al. Expert Opinion on Drug Delivery
- Multi-functional self-assembled nanoparticles for pVEGF-shRNA loading and anti-tumor targeted therapy
- (2019) Sai Lu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
- (2019) Zuan-Fu Lim et al. Journal of Hematology & Oncology
- Updates on the use of liposomes for active tumor targeting in cancer therapy
- (2019) Wei Yan et al. Nanomedicine
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery
- (2018) Giulio Caracciolo et al. ACS Applied Materials & Interfaces
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting forkhead box M1 transcription factor in breast cancer
- (2018) Ruth M. O'Regan et al. BIOCHEMICAL PHARMACOLOGY
- Metabolomics facilitates the discrimination of the specific anti-cancer effects of free- and polymer-conjugated doxorubicin in breast cancer models
- (2018) Ana Armiñán et al. BIOMATERIALS
- Endothelial growth factor receptor-targeted and reactive oxygen species-responsive lung cancer therapy by docetaxel and resveratrol encapsulated lipid-polymer hybrid nanoparticles
- (2018) Zizheng Song et al. BIOMEDICINE & PHARMACOTHERAPY
- HER2Deregulation in Lung Cancer: Right Time to Adopt an Orphan?
- (2018) Federico Cappuzzo et al. CLINICAL CANCER RESEARCH
- DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition
- (2018) Anita K. Bakrania et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Improving combination cancer therapy: the CombiPlex® development platform
- (2018) Anthony W Tolcher et al. Future Oncology
- SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
- (2018) Yi-Ping Fang et al. International Journal of Nanomedicine
- Glutathione metabolism in cancer progression and treatment resistance
- (2018) Ankita Bansal et al. JOURNAL OF CELL BIOLOGY
- Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells
- (2018) Jitendrakumar Patel et al. JOURNAL OF MICROENCAPSULATION
- KRAS -Mutant Non-Small Cell Lung Cancer: From Biology to Therapy
- (2018) Irene Ferrer et al. LUNG CANCER
- Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer
- (2018) Ayaka Okamoto et al. MOLECULAR PHARMACEUTICS
- Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
- (2018) Lina Liu et al. MOLECULAR THERAPY
- Repolarization of Tumor-Associated Macrophages in a Genetically Engineered Nonsmall Cell Lung Cancer Model by Intraperitoneal Administration of Hyaluronic Acid-Based Nanoparticles Encapsulating MicroRNA-125b
- (2018) Neha N. Parayath et al. NANO LETTERS
- Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment
- (2018) Narsireddy Amreddy et al. Nanomedicine-Nanotechnology Biology and Medicine
- CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer
- (2018) Zhaoxian Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tapping the RNA world for therapeutics
- (2018) Judy Lieberman NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
- (2018) Kristine Astvatsaturyan et al. PLoS One
- Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
- (2018) Laura Vera-Ramirez et al. Nature Communications
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Tapping the RNA world for therapeutics
- (2018) Judy Lieberman NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance
- (2018) Zachary Schrank et al. Cancers
- Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
- (2018) Christiana Neophytou et al. Frontiers in Oncology
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Histone deacetylase 6 in cancer
- (2018) Ting Li et al. Journal of Hematology & Oncology
- A brief report of transformation from Non-small cell to small cell lung cancer: Molecular and therapeutic characteristics
- (2018) Léonie Ferrer et al. Journal of Thoracic Oncology
- Liposomal Irinotecan Achieves Significant Survival and Tumor Burden Control in a Triple Negative Breast Cancer Model of Spontaneous Metastasis
- (2018) Nicholas Bernards et al. MOLECULAR PHARMACEUTICS
- Ultrasound-targeted Photodynamic and Gene Dual Therapy for Effectively Inhibiting Triple Negative Breast Cancer by Cationic Porphyrin Lipid Microbubbles Loading with HIF1α-siRNA
- (2018) shumin wang et al. Nanoscale
- Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer
- (2018) Gamze Guney Eskiler et al. PHARMACEUTICAL RESEARCH
- Uniqueness, Advantages, Challenges, Solutions, and Perspectives in Therapeutics Applying RNA Nanotechnology
- (2018) Peixuan Guo et al. Nucleic Acid Therapeutics
- Integrative analysis of the inter-tumoral heterogeneity of triple-negative breast cancer
- (2018) Alec M. Chiu et al. Scientific Reports
- Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
- (2018) Venus Sosa Iglesias et al. Frontiers in Oncology
- Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug
- (2018) Kai Chen et al. Acta Biomaterialia
- Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer
- (2018) Song Yi Lee et al. BIOMACROMOLECULES
- Lung cancer: active therapeutic targeting and inhalational nanoproduct design
- (2018) Nasser Alhajj et al. Expert Opinion on Drug Delivery
- Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study
- (2018) Chan Wu et al. International Journal of Nanomedicine
- Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN)
- (2018) Bei Xu et al. MEDICINE
- PLGA-Based Nanoparticles in Cancer Treatment
- (2018) Sima Rezvantalab et al. Frontiers in Pharmacology
- Tumor Microenvironment Targeted Nanotherapy
- (2018) Clara Fernandes et al. Frontiers in Pharmacology
- Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy
- (2018) Meghan Leary et al. Cancers
- Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women
- (2018) Rong Wang et al. Frontiers in Oncology
- Engineered beta-cyclodextrin-based carrier for targeted doxorubicin delivery in breast cancer therapy in vivo
- (2018) Hoon Hyun et al. JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
- Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy
- (2018) Caina Xu et al. JOURNAL OF CONTROLLED RELEASE
- MEK inhibitors under development for treatment of non-small-cell lung cancer
- (2017) Chul Kim et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nanomedicine applications in the treatment of breast cancer: current state of the art
- (2017) Di Wu et al. International Journal of Nanomedicine
- Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation
- (2017) Jie Hu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer
- (2017) Douglas R. Vogus et al. JOURNAL OF CONTROLLED RELEASE
- To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes
- (2017) Yannan Dou et al. JOURNAL OF CONTROLLED RELEASE
- The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable
- (2017) Thanyanan Reungwetwattana et al. LUNG CANCER
- Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells
- (2017) Brenda Brenner S. Cerqueira et al. Materials Science & Engineering C-Materials for Biological Applications
- Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence
- (2017) Biagio Ricciuti et al. MEDICAL ONCOLOGY
- Intra-tumor heterogeneity from a cancer stem cell perspective
- (2017) Pramudita R. Prasetyanti et al. Molecular Cancer
- Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
- (2017) Huige Peng et al. NANO LETTERS
- HER2-positive breast cancer targeting and treatment by a peptide-conjugated mini nanodrug
- (2017) Hui Ding et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
- (2017) Alexander Drilon et al. Nature Reviews Clinical Oncology
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Maltodextrin modified liposomes for drug delivery through the blood–brain barrier
- (2017) Zeynep Gurturk et al. MedChemComm
- Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer
- (2017) Rongrong Zhang et al. Drug Design Development and Therapy
- Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience
- (2017) Marcus Vetter et al. Oncotarget
- Intratumoral heterogeneity and clonal evolution in blood malignancies and solid tumors
- (2017) Ignacio Varela et al. Oncotarget
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies
- (2017) Venkata Talluri Siddhartha et al. Artificial Cells Nanomedicine and Biotechnology
- Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models
- (2017) Jing Tian et al. Journal of Materials Chemistry B
- New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
- (2017) Isabel Corraliza-Gorjón et al. Frontiers in Immunology
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- Temperature sensitive liposomes combined with thermal ablation: Effects of duration and timing of heating in mathematical models and in vivo
- (2017) Christian Rossmann et al. PLoS One
- H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer
- (2017) S. Mazzucchelli et al. Scientific Reports
- Recent advances of cocktail chemotherapy by combination drug delivery systems
- (2016) Quanyin Hu et al. ADVANCED DRUG DELIVERY REVIEWS
- Lung Pericytes and Resident Fibroblasts
- (2016) Luke Barron et al. AMERICAN JOURNAL OF PATHOLOGY
- Toxicological Concerns of Engineered Nanosize Drug Delivery Systems
- (2016) Biswajit Mukherjee et al. AMERICAN JOURNAL OF THERAPEUTICS
- New Strategies in Cancer Nanomedicine
- (2016) Rong Tong et al. Annual Review of Pharmacology and Toxicology
- Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer
- (2016) Ashley M. Brinkman et al. BIOMATERIALS
- EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer
- (2016) Xiangyu Zhang et al. DRUG DELIVERY
- Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer
- (2016) Yang Xiong et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives
- (2016) Rui Xue Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
- (2016) Shengpeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment
- (2016) Mingyuan Li et al. PHARMACEUTICAL RESEARCH
- Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer
- (2016) Michail Ignatiadis et al. PLoS One
- Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays
- (2016) Alan Eastman Oncotarget
- Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
- (2016) Young Kwang Chae et al. Oncotarget
- The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
- (2016) Yubing Zhou et al. Oncotarget
- FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
- (2016) Zuhal Hamurcu et al. Oncotarget
- Cancer nanomedicine: is targeting our target?
- (2016) Twan Lammers et al. Nature Reviews Materials
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- “Triple-Punch” Strategy for Triple Negative Breast Cancer Therapy with Minimized Drug Dosage and Improved Antitumor Efficacy
- (2015) Shishuai Su et al. ACS Nano
- Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin
- (2015) Liandong Hu et al. BIOMEDICINE & PHARMACOTHERAPY
- Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic Review and Meta-Analysis
- (2015) Xin-Bin Pan et al. Breast Care
- Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine
- (2015) Radosław Mlak et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer
- (2015) Jenny G. Parvani et al. CANCER RESEARCH
- Are PEGylated liposomes better than conventional liposomes? A special case for vincristine
- (2015) Xuling Wang et al. DRUG DELIVERY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Expression of epithelial-mesenchymal transition–related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
- (2015) Min Hye Jang et al. HUMAN PATHOLOGY
- Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
- (2015) George Mattheolabakis et al. JOURNAL OF DRUG TARGETING
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- PAMAM dendrimers as promising nanocarriers for RNAi therapeutics
- (2015) Prashant Kesharwani et al. Materials Today
- Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer
- (2015) R. Paulmurugan et al. MOLECULAR CANCER THERAPEUTICS
- Nanoparticle uptake: The phagocyte problem
- (2015) Heather Herd Gustafson et al. Nano Today
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- Tissue invasion and metastasis: Molecular, biological and clinical perspectives
- (2015) W.G. Jiang et al. SEMINARS IN CANCER BIOLOGY
- Cancer nanomedicine: from targeted delivery to combination therapy
- (2015) Xiaoyang Xu et al. TRENDS IN MOLECULAR MEDICINE
- Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
- (2015) Murugan Kalimutho et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A drug-specific nanocarrier design for efficient anticancer therapy
- (2015) Changying Shi et al. Nature Communications
- An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids
- (2015) Amar Jyoti et al. Scientific Reports
- RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
- (2015) James Finlay et al. Biomed Research International
- Deptor Enhances Triple-Negative Breast Cancer Metastasis and Chemoresistance through Coupling to Survivin Expression
- (2015) Jenny G. Parvani et al. NEOPLASIA
- Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp
- (2015) Minzhi Zhao et al. PLoS One
- A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
- (2014) A. Awada et al. ANNALS OF ONCOLOGY
- Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer
- (2014) Wenbing Dai et al. BIOMATERIALS
- Cancer active targeting by nanoparticles: a comprehensive review of literature
- (2014) Remon Bazak et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles
- (2014) Yang Liu et al. JOURNAL OF CONTROLLED RELEASE
- Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals
- (2014) Janos Szebeni MOLECULAR IMMUNOLOGY
- cRGD Grafted siRNA Nano-constructs for Chemosensitization of Gemcitabine Hydrochloride in Lung Cancer Treatment
- (2014) Nirav Khatri et al. PHARMACEUTICAL RESEARCH
- Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution
- (2014) Yong Xu et al. Artificial Cells Nanomedicine and Biotechnology
- Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
- (2013) Zhou J. Deng et al. ACS Nano
- Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer
- (2013) Swati Biswas et al. CANCER LETTERS
- Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) Formulation and Paclitaxel in Polyethoxylated Castor Oil: A Randomized, Two-Period Crossover Study in Patients With Advanced Cancer
- (2013) Marije Slingerland et al. CLINICAL THERAPEUTICS
- Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
- (2013) Kunn Hadinoto et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer
- (2013) Michael E. Werner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- nab-Paclitaxel mechanisms of action and delivery
- (2013) Denise A. Yardley JOURNAL OF CONTROLLED RELEASE
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Lung Resistance Protein and Multidrug Resistance Protein in Non-Small Cell Lung Cancer and Their Clinical Significance
- (2013) ZJ Chen et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
- (2013) J. F. Gainor et al. ONCOLOGIST
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer nanomedicines: So many papers and so few drugs!
- (2012) Vincent J. Venditto et al. ADVANCED DRUG DELIVERY REVIEWS
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanotechnology applied to overcome tumor drug resistance
- (2012) Zibin Gao et al. JOURNAL OF CONTROLLED RELEASE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- PEGylated Liposomal Doxorubicin Targeted to α5β1-Expressing MDA-MB-231 Breast Cancer Cells
- (2012) Kamlesh Shroff et al. LANGMUIR
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- Biomolecular coronas provide the biological identity of nanosized materials
- (2012) Marco P. Monopoli et al. Nature Nanotechnology
- Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation
- (2011) J. E. Panoff et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
- (2011) G. P. Stathopoulos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeted drug delivery to tumors: Myths, reality and possibility
- (2011) You Han Bae et al. JOURNAL OF CONTROLLED RELEASE
- Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity
- (2011) Chunlei Li et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
- (2011) János Szebeni et al. Nanomedicine-Nanotechnology Biology and Medicine
- Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
- (2011) Vikash P. Chauhan et al. Annual Review of Chemical and Biomolecular Engineering
- Assessment of the Evolution of Cancer Treatment Therapies
- (2011) Manuel Arruebo et al. Cancers
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment
- (2010) WW Cheng et al. Expert Opinion on Drug Delivery
- Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model
- (2010) Yasemin Çırpanlı et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
- (2010) Wilson H. Roa et al. JOURNAL OF CONTROLLED RELEASE
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
- (2009) Teni Boulikas EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Nanosystem drug targeting: Facing up to complex realities
- (2009) Pakatip Ruenraroengsak et al. JOURNAL OF CONTROLLED RELEASE
- Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo
- (2009) P. G. Tardi et al. MOLECULAR CANCER THERAPEUTICS
- Understanding biophysicochemical interactions at the nano–bio interface
- (2009) Andre E. Nel et al. NATURE MATERIALS
- Overcoming Drug Resistance in Patients with Metastatic Breast Cancer
- (2009) Serena T Wong et al. PHARMACOTHERAPY
- Biofunctionalized targeted nanoparticles for therapeutic applications
- (2008) Andrew Z Wang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now